These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW. Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103 [Abstract] [Full Text] [Related]
16. Results of a screening program for multiple endocrine neoplasia type 2A: a clinical study of a Japanese family. Shimotake T, Iwai N, Yanagihara J, Kobayashi T, Takai S. Henry Ford Hosp Med J; 1989 Dec; 37(3-4):124-6. PubMed ID: 2576943 [Abstract] [Full Text] [Related]
20. The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2. Frilling A, Goretzki PE, Bastian L, Roeher HD. Henry Ford Hosp Med J; 1989 Dec; 37(3-4):122-3. PubMed ID: 2576942 [Abstract] [Full Text] [Related] Page: [Next] [New Search]